Option Care Health (OPCH) Cash & Equivalents (2010 - 2026)

Option Care Health has reported Cash & Equivalents for 16 years, with the latest figure at $177.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 3.47% year-over-year to $177.3 million; the trailing twelve-month figure through Mar 2026 stood at $177.3 million (up 3.47% YoY), and the FY2025 full-year result was $232.6 million, down 43.62% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $177.3 million, down from $232.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $483.0 million in Q3 2024, with the low at $145.6 million in Q1 2022.
• Historically, Cash & Equivalents has averaged $291.2 million across 5 years, with a median of $294.2 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents surged 146.34% — and 2025, when it tumbled 47.25%.
• Option Care Health's Cash & Equivalents stood at $294.2 million in 2022, then increased by 16.88% to $343.8 million in 2023, then climbed by 19.98% to $412.6 million in 2024, then plunged by 43.62% to $232.6 million in 2025, then decreased by 23.77% to $177.3 million in 2026.
• The last three Cash & Equivalents figures came in at $177.3 million (Q1 2026), $232.6 million (Q4 2025), and $309.8 million (Q3 2025), per Business Quant data.